Molecularin Biotech

Molecularin Biotech is a biotechnology company dedicated to the development of long-acting protein therapeutics through its proprietary Molecularin platform. The company's technology focuses on the site-specific modification and stabilization of therapeutic proteins, such as cytokines and metabolic hormones, to improve their safety and efficacy profiles. Its pipeline features candidates targeting oncology, including long-acting IL-2 and IL-15, as well as metabolic disorders like MASH and obesity. Based in Suzhou, China, with operations in the United States, Molecularin leverages its protein engineering expertise to create differentiated treatments for complex diseases.